| 000 | 01436 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511182453.0 | ||
| 264 | 0 | _c19921120 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1992.tb04131.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColeman, M D | |
| 245 | 0 | 0 |
_aThe use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cSep 1992 |
||
| 300 |
_a244-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCimetidine _xpharmacology |
| 650 | 0 | 4 |
_aDapsone _xadverse effects |
| 650 | 0 | 4 |
_aDermatitis Herpetiformis _xcomplications |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethemoglobinemia _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aRhodes, L E | |
| 700 | 1 | _aScott, A K | |
| 700 | 1 | _aVerbov, J L | |
| 700 | 1 | _aFriedmann, P S | |
| 700 | 1 | _aBreckenridge, A M | |
| 700 | 1 | _aPark, B K | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 34 _gno. 3 _gp. 244-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1992.tb04131.x _zAvailable from publisher's website |
| 999 |
_c1396440 _d1396440 |
||